|
Tarzimanova A.I.
Obesity and atrial fibrillation: mechanisms of occurence and current treatment guidelines
|
№7 / 2022
|
|
Lagutina S.N., Zuikova A.A., Dobrynina I.S., Kotova Yu.A.
Assessment of the biodiversity of the intestinal microbiota as a new diagnostic sign of metabolic disorders
|
№4 (приложение) / 2022
|
|
Kucherenko N.G., Bebekh A.N., Umarova I.A., Gorelov A.I.
Dyspnoea and respiratory mechanics disturbances in obesity patients
|
№8 / 2021
|
|
Larina V.N., Bondarenkova A.A.
Clinical observation of a young patient with obesity and COVID-19-associated lung tissue damage
|
№8 / 2020
|
|
Granovskaya M.V., Demidova T.Yu., Zaslavskaya K.Ya., Balykova L.A.
Targeted therapy of COVID-19 in ambulatory-polyclinical practice
|
№8 / 2020
|
|
Volkova A.R., Fishman M.B., Semikova G.V, Somova V.M., Mozgunova V.S.
Clinical predictors of weight regain after bariatric surgery
|
№8 / 2020
|
|
Bobkova I.N., Gussaova S.S., Stavrovskaya E.V.
Kidney damage in case of obesity: variants of clinical course, mechanisms of development
|
№6 / 2019
|
|
Ametov A.S., Rubtsov Yu.E., Saluhov V.V., Khalimov Yu.Sh., Agafonov P.V.
Elimination of adipose tissue dysfunction as a major factor in reducing cardiometabolic risks in obesity
|
№6 / 2019
|
|
Yagoda A.V., Geyvandova T.V., Rogova S.Sh., Geyvandova N.I.
The clinical significance of blood leptin in patients with non-alcoholic fatty liver disease associated with obesity
|
№3 / 2019
|
|
C.G. Shul'kina, E.N. Smirnova
Metabolically healthy obesity - focus on endothelium and inflammation
|
№3 / 2018
|
|
O.A. Gromova, I.Yu. Torshin, V.F. Zgoda, I.К. Tomilova
Molecular mechanisms of action of Laennec against development of metabolic syndrome and obesity
|
№5 / 2017
|
|
A.Ye. Goldshmid., Ye.Yu. Martynova, Yu.Ye. Poteshkin
Obesity: modern concept of diagnosis and treatment
|
№5 / 2017
|
Русский
